TECTONIC THERAPEUTIC, INC. Operating Expenses
TECTONIC THERAPEUTIC, INC. (TECX) reported Operating Expenses of $24.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. operating expenses for the quarter ending 2026-06-30 was $24.22M, a 8.45% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. operating expenses for the quarter ending 2026-03-31 was $27.30M, a 49.20% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. operating expenses for the quarter ending 2025-12-31 was $21.52M, a 53.78% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. operating expenses for the quarter ending 2025-09-30 was $21.89M, a 11.47% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. operating expenses for fiscal 2025 was $84.04M, a 44.85% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. operating expenses for fiscal 2024 was $58.02M, a 29.94% increase from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. operating expenses for fiscal 2023 was $44.65M, a 57.65% decline from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. operating expenses for fiscal 2022 was $105.43M, a 11.28% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $24.22M 10-Q · filed 2026-08-06 | $51.52M 10-Q · filed 2026-08-06 | $73.03M derived: sum of 3 quarters · filed 2026-08-06 | $94.92M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $27.30M 10-Q · filed 2026-05-07 | $48.82M derived: sum of 2 quarters · filed 2026-05-07 | $70.71M derived: sum of 3 quarters · filed 2026-05-07 | $93.04M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $43.41M derived: sum of 2 quarters · filed 2026-02-26 | $65.74M derived: sum of 3 quarters · filed 2026-08-06 | $84.04M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $21.89M 10-Q · filed 2025-11-06 | $44.22M derived: sum of 2 quarters · filed 2026-08-06 | $62.52M 10-Q · filed 2025-11-06 | $76.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $22.33M 10-Q · filed 2026-08-06 | $40.63M 10-Q · filed 2026-08-06 | $54.62M derived: sum of 3 quarters · filed 2026-08-06 | $74.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $18.30M 10-Q · filed 2026-05-07 | $32.29M derived: sum of 2 quarters · filed 2026-05-07 | $51.93M derived: sum of 3 quarters · filed 2026-05-07 | $63.35M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $13.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $33.63M derived: sum of 2 quarters · filed 2026-02-26 | $45.05M derived: sum of 3 quarters · filed 2026-02-26 | $58.02M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $19.64M 10-Q · filed 2025-11-06 | $31.06M derived: sum of 2 quarters · filed 2025-11-06 | $44.02M 10-Q · filed 2025-11-06 | $53.40M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $11.42M 10-Q · filed 2025-08-07 | $24.39M 10-Q · filed 2025-08-07 | $33.76M derived: sum of 3 quarters · filed 2025-08-07 | $43.88M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $12.97M 10-Q · filed 2025-05-08 | $7.94M 10-Q · filed 2024-05-09 | $22.34M derived: sum of 2 quarters · filed 2025-05-08 | $32.46M derived: sum of 3 quarters · filed 2025-05-08 | $43.09M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $19.49M derived: sum of 2 quarters · filed 2025-03-20 | $30.12M derived: sum of 3 quarters · filed 2025-03-20 | $44.65M 10-K · filed 2025-03-20 | $71.67M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | $10.11M 10-Q · filed 2024-11-12 | $21.09M 10-Q · filed 2023-11-09 | $20.75M derived: sum of 2 quarters · filed 2024-11-12 | $35.27M 10-Q · filed 2024-11-12 | $62.04M 10-Q · filed 2023-11-09 | $71.22M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $10.63M 10-Q · filed 2024-08-14 | $15.73M 10-Q · filed 2023-08-10 | $25.16M 10-Q · filed 2024-08-14 | $40.95M 10-Q · filed 2023-08-10 | $61.11M derived: sum of 3 quarters · filed 2024-08-14 | $84.09M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $25.22M 10-Q · filed 2024-05-09 | $50.48M derived: sum of 2 quarters · filed 2024-05-09 | $73.46M derived: sum of 3 quarters · filed 2024-05-09 | $101.24M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $25.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $48.24M derived: sum of 2 quarters · filed 2024-03-14 | $76.02M derived: sum of 3 quarters · filed 2024-03-14 | $105.43M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $22.98M 10-Q · filed 2023-11-09 | $50.76M derived: sum of 2 quarters · filed 2023-11-09 | $80.18M 10-Q · filed 2023-11-09 | $108.14M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $27.77M 10-Q · filed 2023-08-10 | $57.19M 10-Q · filed 2023-08-10 | $85.15M derived: sum of 3 quarters · filed 2023-08-10 | $117.77M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $29.42M 10-Q · filed 2023-05-11 | $57.38M derived: sum of 2 quarters · filed 2023-05-11 | $90.00M derived: sum of 3 quarters · filed 2023-05-11 | $121.38M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $27.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $60.58M derived: sum of 2 quarters · filed 2023-03-23 | $91.96M derived: sum of 3 quarters · filed 2023-03-23 | $118.84M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $32.62M 10-Q · filed 2022-11-08 | $63.99M derived: sum of 2 quarters · filed 2022-11-08 | $90.88M 10-Q · filed 2022-11-08 | $118.94M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $31.38M 10-Q · filed 2022-08-09 | $58.26M 10-Q · filed 2022-08-09 | $86.32M derived: sum of 3 quarters · filed 2022-08-09 | $123.04M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $26.88M 10-Q · filed 2022-05-10 | $54.95M derived: sum of 2 quarters · filed 2022-05-10 | $91.67M derived: sum of 3 quarters · filed 2022-05-10 | $120.52M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $28.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $64.78M derived: sum of 2 quarters · filed 2022-03-17 | $93.64M derived: sum of 3 quarters · filed 2022-03-17 | $120.23M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $36.72M 10-Q · filed 2021-11-04 | $65.58M derived: sum of 2 quarters · filed 2021-11-04 | $92.16M 10-Q · filed 2021-11-04 | $115.60M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $28.86M 10-Q · filed 2021-08-05 | $55.45M 10-Q · filed 2021-08-05 | $78.88M derived: sum of 3 quarters · filed 2021-08-05 | $96.94M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $26.59M 10-Q · filed 2021-05-13 | $50.02M derived: sum of 2 quarters · filed 2021-05-13 | $68.09M derived: sum of 3 quarters · filed 2021-05-13 | $84.70M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $23.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $41.50M derived: sum of 2 quarters · filed 2021-03-18 | $58.11M derived: sum of 3 quarters · filed 2021-03-18 | $75.81M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $18.06M 10-Q · filed 2020-11-05 | $34.68M derived: sum of 2 quarters · filed 2020-11-05 | $52.38M 10-Q · filed 2020-11-05 | $69.05M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $16.61M 10-Q · filed 2020-08-06 | $34.31M 10-Q · filed 2020-08-06 | $50.99M derived: sum of 3 quarters · filed 2020-08-06 | $63.22M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $17.70M 10-Q · filed 2020-05-07 | $34.38M derived: sum of 2 quarters · filed 2020-05-07 | $46.61M derived: sum of 3 quarters · filed 2020-05-07 | $56.16M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $16.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $28.91M derived: sum of 2 quarters · filed 2020-03-16 | $38.45M derived: sum of 3 quarters · filed 2020-03-16 | $46.24M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $12.23M 10-Q · filed 2019-11-07 | $21.78M derived: sum of 2 quarters · filed 2019-08-08 | $29.57M 10-Q · filed 2019-11-07 | $37.00M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-06-30 | $9.55M 10-Q · filed 2019-08-08 | $17.34M 10-Q · filed 2019-08-08 | $24.77M derived: sum of 3 quarters · filed 2019-08-08 | $31.14M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $7.79M 10-Q · filed 2019-05-13 | $15.22M derived: sum of 2 quarters · filed 2019-05-13 | $21.59M derived: sum of 3 quarters · filed 2019-05-13 | $24.13M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $7.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $13.80M derived: sum of 2 quarters · filed 2019-03-25 | $16.34M derived: sum of 3 quarters · filed 2019-03-25 | $18.39M 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | $6.37M 10-Q · filed 2018-11-13 | $8.91M derived: sum of 2 quarters · filed 2018-11-13 | $10.96M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $2.54M 10-Q · filed 2018-08-09 | $4.59M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |